troglitazone has been researched along with chir 99021 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Boyce, RS; Brown, SP; Bussiere, DE; Fang, E; Goff, D; Harrison, SD; Jansen, JM; Johnson, KW; Le, VP; Levine, BH; Ng, SC; Ni, ZJ; Nuss, JM; Pfister, KB; Ramurthy, S; Renhowe, PA; Ring, DB; Shafer, CM; Shu, W; Subramanian, S; Wagman, AS; Zhou, XA | 1 |
| Aoi, T; Fujisawa, M; Hinata, N; Koyanagi-Aoi, M; Suzuki, K; Uehara, K | 1 |
3 other study(ies) available for troglitazone and chir 99021
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.
Topics: Animals; CHO Cells; Chromatography, High Pressure Liquid; Cricetulus; Crystallography, X-Ray; Enzyme Inhibitors; Glycogen Synthase Kinases; Humans; Hypoglycemic Agents; Mass Spectrometry; Proton Magnetic Resonance Spectroscopy; Pyrimidines; Rats; Structure-Activity Relationship | 2017 |
Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium.
Topics: CDX2 Transcription Factor; Cell Differentiation; Cells, Cultured; Dextrans; Endoderm; ErbB Receptors; Fibroblast Growth Factor 10; Fluorescein-5-isothiocyanate; Glycogen Synthase Kinase 3 beta; Humans; Induced Pluripotent Stem Cells; Permeability; PPAR gamma; Pyridines; Pyrimidines; Quinazolines; Recombinant Proteins; Regenerative Medicine; SOXF Transcription Factors; Troglitazone; Urinary Bladder; Uroplakins; Urothelium | 2019 |